IQVIA Holdings Inc. (LON:0JDM)
London · Delayed Price · Currency is GBP · Price in USD 222.08
+0.23 (0.10%)
At close: Dec 19, 2025
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of 28.1 billion as of December 19, 2025. Its market cap has decreased by -3.10% in one year.
Market Cap
28.10B
Enterprise Value
38.12B
Revenue
11.83B
Ranking
n/a
PE Ratio
29.44
Stock Price
222.08
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from 3.50B to 28.10B, an increase of 702.38%. That is a compound annual growth rate of 17.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 28.10B | -1.36% |
| Dec 31, 2024 | 28.49B | -14.06% |
| Dec 29, 2023 | 33.15B | 4.96% |
| Dec 30, 2022 | 31.58B | -20.65% |
| Dec 31, 2021 | 39.81B | 58.21% |
| Dec 31, 2020 | 25.16B | 11.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| GSK plc | 73.11B |
| Haleon | 33.29B |
| Smith & Nephew | 10.48B |
| Convatec Group | 4.72B |
| Hikma Pharmaceuticals | 3.35B |
| HUTCHMED (China) | 1.71B |
| Genus | 1.71B |